SCHEMBL2158149

SCHEMBL2158149

Cc1c[nH]nc1C(=O)Nc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.51
FLT3 P36888 4/20 0.51
CDK2 P24941 3/20 0.51
CCNA2 P20248 1/20 0.51
CCNA1 P78396 1/20 0.51
ALDH1A1 P00352 2/20 0.49
RAB9A P51151 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 1/20 0.48
ATR Q13535 2/20 0.46
NPC1 O15118 3/20 0.45
KMT2A Q03164 2/20 0.45
PRKDC P78527 1/20 0.45
POLB P06746 1/20 0.45
MEN1 O00255 1/20 0.45
ADORA3 P0DMS8 1/20 0.44
HIF1A Q16665 1/20 0.44
RECQL P46063 1/20 0.44
NOTUM Q6P988 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15798269 0.86 CA12 (0.58) FLT3RAB9AKDM4ENPC1KMT2A
SCHEMBL646345 0.82 KMT2A (0.53) FLT3CDK2CCNA2CCNA1ALDH1A1
SCHEMBL13816814 0.81 FLT3 (0.49) HPGDFLT3CDK2CCNA2CCNA1
SCHEMBL672416 0.81 ALDH1A1 (0.50) FLT3CDK2CCNA2CCNA1ALDH1A1
SCHEMBL954249 0.81 ATR (0.54) FLT3CDK2CCNA2CCNA1RAB9A
SCHEMBL5267186 0.80 NAPRT (0.51) FLT3CDK2CCNA2CCNA1ALDH1A1
SCHEMBL26784592 0.80 BCL2 (0.49) FLT3CDK2CCNA2CCNA1ALDH1A1
SCHEMBL957616 0.79 CHRNB2 (0.53) FLT3CDK2CCNA2CCNA1ALDH1A1
SCHEMBL5320018 0.79 NPC1 (0.60) HPGDALDH1A1RAB9ASMN1; SMN2KDM4E
SCHEMBL1495910 0.77 HPGD (0.56) HPGDCDK2ALDH1A1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178148-A1 SUBSTITUTED 5-VINYLPHENYL-1-PHENYL-PYRAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178148-A1 SUBSTITUTED 5-VINYLPHENYL-1-PHENYL-PYRAZOLE CANNABINOID MODULATORS CNR1, CNR2, GPR18 HPGD 1477/4885FLT3 3059/4885CDK2 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.